Clinical trial Recruiting at 1 site Interventional Ages 45 to 75

Psychological treatment for cognitive impairment support

Official title: Evaluation of a Novel Psychological Intervention Tailored for Patients With Early Cognitive Impairment (PIPCI)

Run by Karolinska Institutet · NCT04356924 · Data updated 2026-11-12

This study is testing a new psychological treatment to help people with mild cognitive issues feel better and improve their daily lives.

Quick facts

Study typeInterventional
Ages45 Years to 75 Years
SexAll
Enrollment138 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm, Stockholm County)
StatusRecruiting
StartedSeptember 7, 2023
Main results expectedJune 30, 2026
Study endsJune 30, 2028
Registry record updatedJuly 1, 2025
Trial IDNCT04356924 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals under 75 years old diagnosed with subjective cognitive decline or mild cognitive impairment who experience mild to moderate psychological symptoms.

Probably not a fit

Patients with a diagnosis of dementia or severe psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on providing psychological treatment to individuals experiencing cognitive impairment, specifically those with subjective cognitive decline (SCD) and mild cognitive impairment (MCI). The intervention is based on a novel treatment manual that incorporates cognitive behavioral therapy (CBT) principles, adapted to meet the needs of cognitively affected individuals. The approach aims to facilitate behavioral changes aligned with personal values and long-term goals, while addressing associated psychological symptoms such as anxiety and depression. Participants will receive support through reminders and tailored sessions to enhance their daily functioning and quality of life.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the psychological well-being and daily functioning of patients with cognitive impairment.

How similar studies have gone: Other studies have shown promise in using psychological interventions for cognitive impairment, suggesting that this approach could be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Criteria's for inclusion
* \< 75 years.
* SCD or MCI diagnosis. All cognitive MCI-subtypes are eligible.
* Mild to moderate psychological symptoms that are indicated to be related to the patient's CI. The psychological symptoms should affect the patients daily living and behavior, exemplified by avoidance behavior, social anxiety and perceived stigmatization.
* Fluency in the Swedish language.
* The patients should have access to a mobile telephone to be able to receive reminders via Short Message Service (SMS).
* Signed informed consent.
* Criteria's for exclusion
* Dementia diagnosis and/or occurrence of serious illness and/or injury that requires immediate investigation or treatment of another type, or which is expected to worsen in the coming year (i.e., not including dementia)
* Severe psychiatric comorbidity (e.g., high suicide risk), and/or severe psychiatric disorder. This will be assessed in the MINI evaluation and during the clinical cognitive examination).
* Anti-depressant medication introduced or alterations in dosage \< 6 months ago (i.e., un-stable dose).
* Mini Mental State Examination (MMSE) score \< 26 and/or a Montreal Cognitive Assessment (MoCA) score \< 24.
* Stroke or head trauma \< 6 months ago.
* Substance abuse

Where it's running

  • Karolinska University Hospital
    Stockholm, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.